Company news
Sensei Biotherapeutics, Inc. news in 2025
Sensei Biotherapeutics, Inc.'s news releases, calls and decks from 2025, newest first.
Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results
November 14, 2025
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value
October 30, 2025
Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors
October 20, 2025
Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025
October 17, 2025
Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025
September 23, 2025
Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
September 3, 2025
Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 5, 2025
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
July 30, 2025
Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split
June 13, 2025
Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress
May 6, 2025
Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 2, 2025
Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress
March 28, 2025
Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors
March 27, 2025
Sensei Biotherapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
February 3, 2025
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
January 7, 2025
Decks in 2025
- Corporate Update (October 2025)
Corporate update · 45 slides · Oct 17, 2025
- Investor Presentation (March 2025)
Investor deck · 44 slides · Mar 27, 2025